BROOKE ARNDORFER: Open Payments
NPI 1376649848 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,113 in 58 payments from 14 companies in 2025. Trend: 2023 $2,111 · 2024 $1,355 · 2025 $1,113
Food & beverage: $1,113
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $213 |
| E.R. Squibb & Sons, L.L.C. | 9 | $175 |
| Novartis Pharmaceuticals Corporation | 5 | $114 |
| Lilly USA, LLC | 6 | $105 |
| Janssen Biotech, Inc. | 5 | $103 |
| Regeneron Healthcare Solutions, Inc. | 4 | $88 |
| GENZYME CORPORATION | 4 | $77 |
| UCB, Inc. | 3 | $75 |
| Amgen Inc. | 3 | $57 |
| Smith+Nephew, Inc. | 1 | $28 |
Products named: SKYRIZI, Sotyktu, DUPIXENT, TREMFYA, Bimzelx, COSENTYX, OTEZLA, EBGLYSS.
Industry payments across ND — which companies pay providers there.
